STOCK TITAN

Cresco Labs Opens Sunnyside Destin and St. Petersburg Florida Stores, Expanding Nationwide Retail Footprint to 66 Locations

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, today announced it has expanded its Sunnyside brand in Florida with the opening of two new stores in Destin at 661 Harbor Blvd. and St. Petersburg at 8123 4th St. North. The Company’s Florida retail footprint is now 31 dispensaries. Nationwide, Cresco has 66 operating locations.

Cresco Labs opened two new Florida stores in Destin and St. Petersburg. Pictured: Sunnyside St. Petersburg—North. (Photo: Business Wire)

Cresco Labs opened two new Florida stores in Destin and St. Petersburg. Pictured: Sunnyside St. Petersburg—North. (Photo: Business Wire)

“We continue to invest wisely in significant growth states like Florida which has a continuously growing medical market of over 825,000 qualified patients and the possibility of a 2024 adult-use ballot initiative,” said Charlie Bachtell, Cresco Labs’ CEO & Co-Founder. “Both the Pandhandle and Tampa Bay areas are ideal markets to expand our retail brand and product offering, and we found two great locations on major retail corridors where locals and visitors enjoy shopping, eating and entertainment. Our team is thrilled to start helping patients with their everyday cannabis needs.”

This is the first Sunnyside in Destin that joins other stores in Tallahassee, Panama City and Pensacola (9th Ave. and Nine Mile R.) in serving patients in the Panhandle region. In St. Petersburg, this is the Company’s second location strategically located on the north side of the city to serve patients in the Tampa Bay region alongside Sunnyside St. Petersburg South and Clearwater stores.

Both Sunnyside Destin and Sunnyside St. Petersburg North will provide a wide assortment of accessories and products from the Company’s branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. Patients can now enjoy more flavors from Sunnyside’s Chews edibles line, which already accounts for 10% of Sunnyside sales in the state, as well as additional flavors and effects from Good News, such as Vegas which boasts elevated effects with caffeine.

Patients can place orders today both in store and online through the retailer’s Sunnyside.shop website. Store hours are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

For more information, visit www.Sunnyside.shop.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated, multi-state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco®, High Supply®, Mindy’s™, Good News®, Remedi™, Wonder Wellness Co.® and FloraCal Farms®. Cresco Labs’ national dispensary brand, Sunnyside®, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED™, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs
Twitter: Cresco Labs
LinkedIn: Cresco Labs

Media:

Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

Investors:

Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

investors@crescolabs.com

For general Cresco Labs inquiries:

312-929-0993

info@crescolabs.com

Source: Cresco Labs

CRESCO LABS INC

OTC:CRLBF

CRLBF Rankings

CRLBF Latest News

CRLBF Stock Data

369.93M
326.49M
0.66%
7.85%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago